key: cord-1041388-vuzqha32
authors: Kafes, Habibe; Can, Irem Dilara; Yaman, Nezaket Merve; Kara, Meryem; Korkmaz, Ahmet; Ozeke, Ozcan; Cay, Serkan; Ozcan, Firat; Topaloglu, Serkan; Aras, Dursun
title: Ajmaline-induced Brugada Phenocopy, Right Bundle Branch Block, or Both?
date: 2021-09-15
journal: J Innov Card Rhythm Manag
DOI: 10.19102/icrm.2021.120906
sha: 6d6c7c4f5bdeb790e185ae589297124c66afc577
doc_id: 1041388
cord_uid: vuzqha32

In equivocal or suspected cases of Brugada syndrome (BrS), ajmaline testing is frequently used in the diagnostic approach. However, the administration of sodium channel blockers can not only elicit the coved ST-segment elevation characteristic of type 1 Brugada pattern but also induce right bundle branch block (RBBB), which can preclude the electrocardiographic manifestations of BrS. We describe a case report wherein RBBB posed a diagnostic challenge during the ajmaline test for suspected BrS.

A 28-year-old Caucasian man was referred to our center because of a possible right bundle branch block (RBBB) electrocardiographic (ECG) pattern recorded during a medical evaluation for suspected coronavirus disease 2019 infection (Figure 1 ). His physical examination was unremarkable. There was no family history of syncope or sudden cardiac death.

At first glance, the patient had sinus rhythms with an atypical appearance of RBBB. Indeed, RBBB is generally considered a benign finding that does not imply an increased risk when found in asymptomatic healthy individuals. 1 However, the presence of it in subjects affected by cardiomyopathies or channelopathies may conceal the underlying ECG changes, thus making the diagnosis of such conditions more challenging. Its atypical appearance in the current case led us to consider that a type 1 Brugada ECG pattern would be hidden or "masked" by the underlying RBBB 2 ; then, we ordered a higher intercostal space ECG, which showed the resolution of RBBB ( Figure 2 ). However, although the changes related to the RBBB also resolved on the frontal leads, we could not rule out a history of intermittent RBBB. The diagnostic drug challenge performed by intravenous administration of ajmaline (1 mg/kg over five minutes) by specifically designed electrograms covering the right ventricular outflow tract 3 ( Figure 3A ) unmasked a diffuse abnormal response compatible with the type 1 Brugada syndrome (BrS)-like ECG pattern superimposed on the pre-existing atypical RBBB during 30 seconds of infusion ( Figure 3B ), and the infusion was immediately stopped at that stage. After complete resolution of the electrogram (Figure 3C) , we readministered ajmaline, which also showed ST-segment elevation in the precordial leads as a reproducible finding ( Figure 3D ).

Indeed, Brugada and Brugada initially described an RBBB pattern among their eight cases of BrS. 3 Thereafter, it was shown that, although the presence of the RBBB pattern is not necessary for reaching a diagnosis of BrS, it is supportive. In RBBB in healthy subjects, the ST segment is usually not elevated in the right precordial leads. In RBBB patients, activation of the entire right ventricle was delayed, while, in contrast, delayed activation was confined to the right ventricular outflow tract in BrS patients. 4 Therefore, BrS patients do not have the wide final S-waves in the left leads (I, aVL, V5, and V6) necessary for RBBB. However, the presence of a wide and/or large S-wave in lead I has been found to be a powerful predictor of life-threatening ventricular arrhythmias in patients with BrS. 5 Furthermore, the characteristic ECG pattern of BrS can be masked by complete RBBB and exposed by the resolution of the block or pharmacological or pacing maneuvers. 2, 6, 7 In the presence of complete RBBB, the premature activation of the right ventricle by apical pacing caused fusion beats, with narrower QRS complexes disclosing the distinctive coved-type ST-segment elevation in the right precordial leads. 8 Thus, BrS should be ruled out whenever a slight ST-segment elevation is observed in the right precordial leads in the presence of RBBB. 6, 8 In equivocal or suspected cases of BrS, ajmaline testing is frequently used in the diagnostic approach. 9-12 However, some authors have reported a potential 5% false-positive rate, thus making the universal interpretation of provocative drug testing challenging. 13, 14 Therefore, not only diagnostic decisions but also therapeutic choices with long-term implications were adopted worldwide before the potential for false-positive results of the ajmaline test was fully appreciated. 13 Clinicians should consider all alternative causes in unexplained cardiac arrest and avoid ajmaline doses of greater than 1 mg/kg. 15 Furthermore, it should be kept in mind that the administration of sodium channel blockers could not only elicit the coved ST-segment elevation characteristic of type 1 Brugada pattern but also induce an RBBB that can preclude the ECG manifestations of BrS. 16 As placing the right precordial ECG leads at an upper position (second or third intercostal space) increases the sensitivity of ECG to detect all types of BrS, 3 it would be nice to take an ECG at upper intercostal spaces and perform an ajmaline test to unmask the true RBBB effect. 

Right bundle branch block: prevalence, incidence, and cardiovascular morbidity and mortality in the general population

Brugada syndrome with early repolarization masked by complete right bundle-branch block

How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia

Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients

A new electrocardiographic marker of sudden death in brugada syndrome: the S-wave in lead I

Brugada syndrome behind complete right bundle-branch block

Do patients with electrocardiographic Brugada type 1 pattern have associated right bundle branch block? A comparative vectorcardiographic study

Highdegree right bundle branch block obscuring the diagnosis of Brugada electrocardiographic pattern

Should all individuals with suspected arrhythmias but initially nondiagnostic electrocardiogram be ordered routinely higher intercostal space ECG?

Should all individuals with a non-diagnostic electrocardiogram undergo ajmaline challenge to unmask the concealed arrhythmic overlap syndromes?

Epsilon-like electrocardiographic pattern in a patient with Brugada syndrome

Brugada-type electrocardiographic pattern induced by fever

Read my lips: a positive ajmaline test does not always mean you have brugada syndrome

Drug provocation testing in brugada syndrome: a test of uncertain significance

Yield and pitfalls of ajmaline testing in the evaluation of unexplained cardiac arrest and sudden unexplained death: single-center experience with 482 families

Masquerading bundle branch block obscuring the diagnosis of Brugada syndrome: an electrocardiographic and vectorcardiographic study